20 Matching Annotations
  1. Aug 2022
    1. Thuluva, S., Paradkar, V., Turaga, K., Gunneri, S., Yerroju, V., Mogulla, R., Kyasani, M., Manoharan, S. K., Medigeshi, G., Singh, J., Shaman, H., Singh, C., & Rao, A. V. (2022). Selection of optimum formulation of RBD-based protein sub-unit covid19 vaccine (Corbevax) based on safety and immunogenicity in an open-label, randomized Phase-1 and 2 clinical studies (p. 2022.03.08.22271822). medRxiv. https://doi.org/10.1101/2022.03.08.22271822

  2. Feb 2022
  3. Dec 2021
    1. mechanism responsible for blood clots arising from thrombosis with thrombocytopenia syndrome (TTS) following vaccination with AstraZeneca vaccine.

      covishield vaccine clotting problem

  4. Nov 2021
  5. Oct 2021
  6. Sep 2021
  7. Jun 2021
  8. May 2021
  9. Apr 2021